Primary information |
---|
sequence ID | Seq_3029 |
Peptide sequence | GPPPPPGKPQ |
CancerPDF_ID | CancerPDF_ID3866, CancerPDF_ID3867, CancerPDF_ID3868, CancerPDF_ID3885, CancerPDF_ID3886, CancerPDF_ID3887, CancerPDF_ID3907, CancerPDF_ID3908, CancerPDF_ID3909, CancerPDF_ID3910, CancerPDF_ID13496, |
PMID | 22809520,22809520,22809520,22809520,22809520,22809520,22809520,22809520,22809520,22809520,20974924 |
Protein Name | Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic salivary proline-rich protein 2 |
UniprotKB Entry Name | PRP1_HUMAN,PRP1_HUMAN,PRP1_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRB2_HUMAN |
Fluid | Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Plasma |
M/Z | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,971.531 |
Charge | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2 |
Mass (in Da) | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
fdr | 1275.74,1579.94,1317.75,1317.75,1318.74,1275.74,1317.75,1318.74,1579.94,1275.74,NA |
Profiling Technique | LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS |
Peptide Identification technique | MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,LC-MS/MS |
Quantification Technique | "2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay",NA |
Labelled/Label Free | Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Label Free |
FDR | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
CancerPDF_ID | CancerPDF_ID3866, CancerPDF_ID3867, CancerPDF_ID3868, CancerPDF_ID3885, CancerPDF_ID3886, CancerPDF_ID3887, CancerPDF_ID3907, CancerPDF_ID3908, CancerPDF_ID3909, CancerPDF_ID3910, CancerPDF_ID13496, |
p-Value | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
Software | MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT and SEQUEST |
Length | 10,10,10,10,10,10,10,10,10,10,NA |
Cancer Type | Normal,Normal,Normal,Normal,Normal,Normal,Normal,Normal,Normal,Normal,"Multiple myeloma patients, Acute myeloid leukemia" |
Database | SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),Uniprot database |
Modification | iTRAQ8plex at N-term; iTRAQ8plex(K) at 8,iTRAQ8plex at N-term; iTRAQ8plex(K) at 8,iTRAQ8plex at N-term; iTRAQ8plex(K) at 8,AcetylatN-term; iTRAQ8plex(K)at8,CarbamylatN-term; iTRAQ8plex(K)at8,iTRAQ8plexatN-term; iTRAQ8plex(K)at8,NA,NA,NA,NA,NA |
Number of Patients | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
Regulation | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
Validation | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
Sensitivity | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
Specificity | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
Accuracy | NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA |
Peptide Atlas | NA |
IEDB | 437706
|